Skip to content

4Accepted Jan 13, 5:22 PM ET

Chevallard Daniel R. 4

LENZLENZ Therapeutics, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

5:22 PM

Jan 13, 2025

Filed

Jan 13, 2025

Documents

4

Size

433.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.